Topical 0.4% Ketorolac and Vitreoretinal Surgery

NCT00576329 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Emory University